本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Collegium Pharmaceutical, Inc.

22.38
+0.19000.86%
盤後22.380.00000.00%19:30 EDT
成交量:70.74萬
成交額:1,581.13萬
市值:7.29億
市盈率:17.62
高:22.64
開:22.36
低:22.08
收:22.19
52周最高:50.79
52周最低:21.65
股本:3,255.56萬
流通股本:3,136.51萬
量比:0.79
換手率:2.26%
股息:- -
股息率:- -
每股收益(TTM):1.27
每股收益(LYR):1.73
淨資產收益率:17.61%
總資產收益率:5.75%
市淨率:2.34
市盈率(LYR):12.94

資料載入中...

2024/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/10

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/29

重要事件披露

Form 8-K - Current report
2024/04/11

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities